| Literature DB >> 27957217 |
Abstract
Stroke is a focal neurological syndrome of vascular basis, which may be due to ischemic thrombo-embolism or intra-cerebral haemorrhage. This condition has to be treated on emergency basis as it may cause an irreversible neurological damage. Warfarin has been a widely used oral anti-coagulant in treating ischemic stroke patients. This review highlights the benefits and challenges of warfarin treatment in stroke patients and discusses about the importance of risk stratification scores and bleeding scores in estimating the bleeding risk associated with warfarin treatment. This review also highlights the use of stroke outcome measures in identifying the patients with post-stroke disabilities to provide patient specific treatment.Entities:
Keywords: Ischemic Stroke; Risk Stratification Schemes; Stroke; Stroke Outcome Measures; Stroke Outcomes; Warfarin Treatment
Year: 2015 PMID: 27957217 PMCID: PMC5135176 DOI: 10.4022/jafib.1144
Source DB: PubMed Journal: J Atr Fibrillation ISSN: 1941-6911